12.5 Palliative and End-of-Life Care in Advanced Cardiac Disease

Palliative Care Is Concurrent, Not Terminal

Palliative care is specialized care focused on relief of symptoms and on communication about goals for people with serious illness. It is delivered alongside disease-directed therapy and is appropriate from the time advanced heart disease is diagnosed. It is not a synonym for hospice, does not require a prognosis of six months, and does not require stopping guideline-directed medical therapy, inotropes, dialysis, or device support. A patient can be on dobutamine, listed for transplant, and receiving palliative care on the same day. Hospice by contrast is a Medicare benefit for patients with a prognosis of six months or less who are electing comfort-focused care.

The distinction matters clinically because it changes when the referral is made. Referral framed as "palliative care is what we call when there is nothing left" produces late referrals, unmanaged dyspnea, avoidable ICD shocks in the last hours of life, and families making high-stakes decisions in a crisis with no preparation.

Why Heart Failure Prognostication Is Harder Than Cancer

Advanced cancer typically follows a relatively predictable decline over weeks to months, which makes a hospice conversation naturally timed. Advanced heart failure follows a sawtooth trajectory: a gradual functional decline punctuated by acute decompensations, each followed by a partial recovery to a lower baseline, with a persistent 30-50% probability that death will come suddenly from an arrhythmia rather than at the end of a decline. Two consequences follow directly:

1. There is rarely an obvious moment when the patient "becomes" terminal, so waiting for one guarantees the conversation happens too late or not at all.
2. Because sudden death is a real possibility at every stage, advance care planning and device discussions must occur while the patient is well enough to participate, not during the admission that turns out to be the last one.

Triggers for a Palliative Care Referral in Cardiac Care

• Two or more heart failure hospitalizations in 12 months, or a hospitalization with progressive decline
• NYHA class IV symptoms, or persistent class III with poor quality of life
• Cardiogenic shock, or escalating and now continuous inotrope dependence
• Evaluation for destination-therapy LVAD, where a palliative care consult is an expected part of the pre-implant process
• Transplant or LVAD ineligibility, or removal from a transplant list
• Frequent ICD shocks, particularly appropriate shocks for recurrent ventricular arrhythmias
• Progressive cardiorenal syndrome, diuretic resistance, hypotension limiting guideline-directed therapy, cachexia, or a declining serum sodium
• Symptom burden out of proportion to objective disease, or unaddressed caregiver strain
• The surprise question: "Would I be surprised if this patient died within the next 12 months?" A "no" is a referral trigger.

Advance Care Planning and Surrogate Decision-Making

Surrogate decision-making standards, applied in order:

1. Expressed wishes - clear, applicable prior statements by the patient, written or verbal
2. Substituted judgment - what this particular patient, with their values, would choose in this situation. The surrogate's job is to represent the patient's voice, not to state their own preference
3. Best interests - used only when the patient's values are genuinely unknown; a weighing of burdens and benefits

A nurse who hears a family member say "I couldn't live with myself if we stopped" can reframe gently toward substituted judgment: "What would he say if he could sit up and hear all this?" That reframing reduces surrogate guilt and is one of the most valuable communication moves in cardiac critical care.

Cardiac Device Issues at the End of Life

This is the content that distinguishes cardiac end-of-life nursing from general end-of-life nursing, and it is tested.

ICD Deactivation

An implantable cardioverter-defibrillator (ICD) that fires during the dying process converts a peaceful death into a painful one and distresses the family who watch it. Shocks are common in the final weeks: a substantial minority of ICD patients receive shocks in the last hours to days of life, and many are receiving them because no one raised the subject.

The principles:

• Deactivation is ethically and legally permissible. It is the withdrawal of an unwanted life-sustaining treatment, which competent patients and their surrogates may decline. Professional societies (HRS, ACC, AHA and international counterparts) explicitly endorse this. It is not physician-assisted death or euthanasia - the patient dies of the underlying disease.
• Raise it early. The right time is at hospice enrollment, at a transition to comfort-focused goals, at the DNR conversation, or ideally at implant as part of routine informed consent. Waiting until the patient is actively dying guarantees a rushed, distressing conversation.
• A DNR order does not automatically deactivate an ICD. The device must be addressed separately and explicitly, and it must be documented as its own order.
• Magnet application is the temporary measure; reprogramming is definitive. Placing and securing a clinical magnet over the generator suspends tachyarrhythmia detection and shock delivery for as long as it stays in place, which is why it is used at home, at night, or while awaiting the device service.
• Know what a magnet does to what device. Over an ICD, a magnet suspends shocks and antitachycardia pacing but does not change bradycardia pacing. Over a standalone pacemaker, a magnet causes asynchronous pacing at a fixed rate - a completely different effect. Confusing the two is a classic exam trap.
• Pacing is usually left on. Bradycardia pacing is generally not withdrawn, because it is not preventing a comfortable death and in a pacemaker-dependent patient turning it off can cause immediate symptomatic bradycardia or asystole. The usual plan is to turn off shocks and leave pacing alone.

LVAD and Mechanical Circulatory Support Deactivation

Deactivating a left ventricular assist device (LVAD) is likewise a permissible withdrawal of unwanted treatment, but it differs from ICD deactivation in that death typically follows within minutes to hours. It requires deliberate preparation: the family present and prepared, symptom medications (opioid and benzodiazepine) drawn up and given before the pump is stopped, alarms silenced in advance, the setting chosen (many patients wish to be at home or in a private room), and a clear plan for who performs the stop. The same framework applies to withdrawal of ECMO, intra-aortic balloon counterpulsation, or Impella, and to stopping dialysis in the patient who chooses comfort, where death typically follows over days with uremia, and where sedation and symptom control are planned in advance.

Symptom Management at the End of Life in Advanced Heart Failure

Deprescribing is part of comfort care. Statins, most antihyperglycemics, bisphosphonates, anticoagulation in a bleeding patient, and drugs whose benefit is measured in years can be stopped. Beta-blockers and renin-angiotensin blockers are often reduced or stopped as blood pressure falls, but neurohormonal agents may be continued when they are relieving symptoms; diuretics and antiarrhythmics used for symptom control are typically continued.

Communication Skills

Communication is a procedure with a technique, and the frameworks are testable.

SPIKES for delivering serious news:

1. Setting - private space, sitting down, family present, pager handed off, interruptions eliminated
2. Perception - "What is your understanding of where things stand?" Start by listening
3. Invitation - ask how much detail the patient or family wants and how they want it framed
4. Knowledge - give a brief warning shot, then plain language in short chunks, no jargon, no euphemism
5. Emotions - respond to emotion before giving more information; use NURSE statements (Name, Understand, Respect, Support, Explore) and tolerate silence
6. Strategy and summary - a concrete plan and a clear next step

Ask-Tell-Ask for every information exchange: ask what they already know, tell one piece of information in plain words, then ask what they took from it. It prevents the common failure of a fluent, well-organized explanation that no one in the room absorbed.

Additional principles: name prognosis honestly in ranges ("hours to days," "weeks to months") rather than false precision or false reassurance; use "I wish" statements to align with the family while being truthful ("I wish we had a treatment that could reverse this"); avoid "do you want us to do everything?" - which offers a menu of interventions rather than eliciting goals - and instead ask what matters most and what the patient would find unacceptable; and practice cultural humility, recognizing that norms about disclosure, family-centered decision-making, and hospice acceptance vary widely and that a professional interpreter, not a family member, is required for a goals-of-care conversation across a language barrier.

Hospice Eligibility in Heart Disease

General guidance for heart disease hospice eligibility includes NYHA class IV symptoms at rest despite optimal medical therapy, an ejection fraction of 20% or less as supporting evidence, and supportive findings such as symptomatic recurrent arrhythmias resistant to therapy, prior cardiac arrest or unexplained syncope, cardiogenic brain embolism, or concurrent HIV disease. Inotrope dependence and repeated hospitalizations support eligibility. In practice, patients receiving continuous home inotropes are increasingly served by hospice programs willing to continue the infusion for symptom control - it is worth checking local program capability rather than assuming inotropes disqualify a patient.

Family, Team, and the Nurse

Family and caregiver support: caregivers of advanced heart failure patients carry high rates of depression, anxiety, and financial strain. Practical support - respite, home health, medication cost assistance, an explicit plan for what to do when breathlessness worsens at 2 a.m. - reduces crisis calls and unwanted readmissions. Family presence during resuscitation should be offered with a dedicated staff member assigned to support them.

Bereavement: anticipatory guidance about what dying will look like (changed breathing patterns, mottling, decreased intake, terminal secretions) reduces fear and later distress. Follow-up bereavement contact is a standard hospice component and is increasingly offered by ICUs.

Organ and tissue donation: the referral to the organ procurement organization is made by the hospital per federal requirement and by protocol, and it must occur before any donation discussion with the family. The clinical team does not approach the family about donation; trained requestors do, so that the withdrawal decision remains uncoupled from the donation question. Donation after circulatory death may be an option for cardiac patients withdrawn from support, and offering the family the opportunity to donate is often experienced as meaningful.

Moral distress in the nursing team - knowing the ethically appropriate action but being constrained from taking it - is prevalent in cardiac critical care, particularly around perceived non-beneficial aggressive treatment. The AACN Healthy Work Environment standards (skilled communication, true collaboration, effective decision-making, appropriate staffing, meaningful recognition, and authentic leadership) provide the structural remedy, and AACN's 4A's framework - Ask, Affirm, Assess, Act - provides the individual one: ask whether what you feel is moral distress, affirm your obligation to act, assess the sources and the risks and benefits of acting, and act with a specific plan, then re-evaluate. Ethics consultation, structured debriefing after a difficult death, and interdisciplinary family meetings are the practical levers a bedside nurse can pull.